ReviewFrontiers in network physiology2026
The bed nucleus of the stria terminalis as a neuromodulatory target for refractory epilepsy.
Review in Frontiers in network physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Refractory epilepsy remains a significant clinical challenge, affecting over a third of patients with epilepsy and drastically increasing their risk of sudden unexpected death in epilepsy (SUDEP). Furthermore, psychiatric comorbidities - such as depression and anxiety disorders - are highly prevalent among patients with epilepsy. As neuromodulatory therapeutic approaches evolve, it is paramount that novel targets for stimulation are explored that may concomitantly reduce seizure burden, ameliorate psychiatric comorbidities, and/or reduce SUDEP risk. Here, we review physiological factors that are thought to contribute to SUDEP and which may reduce risk of SUDEP if addressed therapeutically, then we describe how the bed nucleus of the stria terminalis (BNST) represents a forebrain limbic region that concurrently influences many of these physiological processes. We conclude by synthesizing recent findings regarding the BNST in patients and preclinical models of epilepsy and propose that this evidence positions the BNST as a promising extra-thalamic target for therapeutic neurostimulation in patients with refractory epilepsy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.